A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving protease (ADAMTS13) due to autoantibodies that are directed towards ADAMTS13. We report a case of a 46-year-old man who presented with most of the classic clinical manifestations of TTP.
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Digital revista |
| Langue: | English |
| Publié: |
South African Medical Association
2016
|
| Accès en ligne: | http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742016000700023 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|